PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

The Pipeline: Pressures from Beyond

Flipping the Generics Map: Apotex's Jeremy Desai

Building Market Access Competencies for the Future

Feature Article

Pharm Exec's 2017 Pipeline Report

The industry is readying for a leap into a new age of complex therapies. Elaborate manufacturing and soaring drug costs, however, loom as deep chasms to cross in bridging the potential with reality. Casey McDonald reports.
... /Read more/

Regulatory Affairs

Trump Triumph Puts Health Policy in Play

The surprise victory of Donald Trump opens the door to new strategies for providing healthcare to Americans, including coverage and oversight of prescription drugs.
... /Read more/

Strategy

8 Winning Commercial Portfolio Strategies

Biopharma companies are increasingly leveraging product portfolios to own and dominate strategically important therapeutic areas, writes Stan Bernard.
... /Read more/

Strategy

Digital Disruption is Coming: Are You Ready?

The steps to stay ahead of the looming shakeup in pharma. Peter Gassner reports.
... /Read more/

Calendar

/ Specialty Product Data Strategies Summit /

/ 12th Life Sciences Trade and Channel Strategies /

/ PCC 2017 - CBI's 14th Annual Pharmaceutical Compliance Congress /

Marketing and Promotion

Loss of Exclusivity: Strategies to Maximize Product Value

Loss of exclusivity (LOE) doesn't have to be the death knell for branded drug revenue streams. The key approaches to preserving meaningful value well into the post-patent-loss future are outlined.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com